This study is currently not recruiting participants.

A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination with Sofosbuvir for the Treatment of Post-Liver Transplant Subjects with Chronic Hepatitis C

Investigational Treatment for Chronic Hepatitis C After Liver Transplant

Not Recruiting
18 years - 100 years
All
Phase N/A

Brief description of study.

The purpose of this study is to provide an investigational treatment regimen of Daclatasvir plus Sofosbuvir used in combination for 24 weeks in post-liver transplant subjects who have recurrent chronic Hepatitis C Virus (HCV) infection who have a serious or life-threatening condition.

Detailed description of study

The purpose of this study is to provide daclatasvir (DCV) for 24 weeks to be given in combination with sofosbuvir(SOF) to post-liver transplant subjects with chronic hepatitis C recurrence and who have a serious or immediately life-threatening condition, or experienced an event that has decreased their life expectancy to

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: hepatitis
  • Age: 18 years - 100 years
  • Gender: All

This study investigates an investigational treatment for people who have had a liver transplant and now have chronic Hepatitis C Virus (HCV) infection. Hepatitis C is a liver disease caused by the Hepatitis C Virus. It can lead to serious liver problems, especially in people who have had a liver transplant.

Participants in this study will receive an investigational treatment that combines two medicines for 24 weeks. This treatment aims to manage the recurrence of Hepatitis C after a liver transplant.

  • Who can participate: Adults aged 18 and older who have undergone a liver transplant and have a chronic Hepatitis C infection may be eligible. Additional eligibility criteria may apply.
  • Study details: Participants will engage in study visits and follow-ups to monitor the effectiveness of the treatment in managing Hepatitis C recurrence after a liver transplant.
  • Study Timelines: The study will last 24 weeks.
Updated on 19 Feb 2024. Study ID: 1408756419

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team